Shedding microvesicles: artefacts no more.

The small vesicles shed from the surface of many cells upon stimulation, considered for a long time to be artefacts, are now recognized as specific structures that are distinct from the exosomes released upon exocytosis of multivesicular bodies. Recent reports indicate that shedding vesicles participate in important biological processes, such as the surface-membrane traffic and the horizontal transfer of protein and RNAs among neighboring cells, which are necessary for the rapid phenotype adjustments in a variety of conditions. In addition, shedding vesicles have important physiological and pathological roles: in coagulation, by mediating the coordinate contribution of platelets, macrophages and neutrophils; in inflammatory diseases, via the release of cytokines; and in tumor progression, facilitating the spreading and release of cancer cells to generate metastases.

[1]  C. Hess,et al.  Polymorphonuclear Neutrophil-Derived Ectosomes Interfere with the Maturation of Monocyte-Derived Dendritic Cells1 , 2008, The Journal of Immunology.

[2]  Z. Fishelson,et al.  Emission of membrane vesicles: roles in complement resistance, immunity and cancer , 2005, Springer Seminars in Immunopathology.

[3]  M. Salamone,et al.  Intracellular trafficking of endogenous fibroblast growth factor‐2 , 2008, The FEBS journal.

[4]  E. Rodriguez-Boulan,et al.  Itinerant exosomes: emerging roles in cell and tissue polarity. , 2008, Trends in cell biology.

[5]  J. Meldolesi,et al.  Regulated exocytosis: a novel, widely expressed system , 2002, Nature Cell Biology.

[6]  A. Tedgui,et al.  Microparticles and type 2 diabetes. , 2008, Diabetes & metabolism.

[7]  P. K. Wright Targeting vesicle trafficking: an important approach to cancer chemotherapy. , 2008, Recent patents on anti-cancer drug discovery.

[8]  M. Ratajczak,et al.  Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes , 2006, Cancer Immunology, Immunotherapy.

[9]  G. Savettieri,et al.  Astrocytes shed extracellular vesicles that contain fibroblast growth factor-2 and vascular endothelial growth factor. , 2008, International journal of molecular medicine.

[10]  J. Heemskerk,et al.  Shedding of procoagulant microparticles from unstimulated platelets by integrin‐mediated destabilization of actin cytoskeleton , 2006, FEBS letters.

[11]  G. Majno,et al.  Acute inflammation. A review. , 1977, The American journal of pathology.

[12]  Anna Janowska-Wieczorek,et al.  Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer , 2005, International journal of cancer.

[13]  P. Altevogt,et al.  ADAM10‐mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  Z. Fishelson,et al.  Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis. , 2005, International immunology.

[15]  S. Kunapuli,et al.  Role of P2Y receptor subtypes in platelet-derived microparticle generation. , 2008, Frontiers in bioscience : a journal and virtual library.

[16]  J. Meldolesi,et al.  Synaptic vesicles: is kissing a matter of competence? , 2001, Trends in cell biology.

[17]  Lianbo Yu,et al.  Detection of microRNA Expression in Human Peripheral Blood Microvesicles , 2008, PloS one.

[18]  F. Court,et al.  Schwann Cell to Axon Transfer of Ribosomes: Toward a Novel Understanding of the Role of Glia in the Nervous System , 2008, The Journal of Neuroscience.

[19]  Petra Schwille,et al.  Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes , 2008, Science.

[20]  D. Crossman,et al.  Secretion of Intracellular IL-1 Receptor Antagonist (Type 1) Is Dependent on P2X7 Receptor Activation1 , 2004, The Journal of Immunology.

[21]  Spek Ca Tissue factor: from 'just one of the coagulation factors' to a major player in physiology. , 2004 .

[22]  Vincenza Dolo,et al.  Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. , 2002, The American journal of pathology.

[23]  S. Canevari,et al.  Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. , 1998, Cancer research.

[24]  G. Taraboletti,et al.  Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles. , 2008, Neoplasia.

[25]  T. Möller,et al.  Astrocyte-Derived ATP Induces Vesicle Shedding and IL-1β Release from Microglia1 , 2005, The Journal of Immunology.

[26]  D. Pisetsky,et al.  The Role of Microparticles in Inflammation and Thrombosis , 2007, Scandinavian journal of immunology.

[27]  F. Saladino,et al.  The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. , 1998, Anticancer research.

[28]  Klaus Ley,et al.  The platelet microparticle proteome. , 2005, Journal of proteome research.

[29]  Z. Fishelson,et al.  Live Cell Imaging of Outward and Inward Vesiculation Induced by the Complement C5b-9 Complex* , 2007, Journal of Biological Chemistry.

[30]  D. Pisetsky,et al.  Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. , 2005, Arthritis and rheumatism.

[31]  Miguel Ángel Martínez,et al.  Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization , 2006, Proteomics.

[32]  G. Raposo,et al.  Exosomes: endosomal-derived vesicles shipping extracellular messages. , 2004, Current opinion in cell biology.

[33]  H. Brühl,et al.  Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection , 2000, Nature Medicine.

[34]  G. Grondin,et al.  Shedding of vesicular material from the cell surface of eukaryotic cells: different cellular phenomena. , 1991, Biochimica et biophysica acta.

[35]  J Ratajczak,et al.  Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.

[36]  R. Flaumenhaft,et al.  Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. , 2009, Blood.

[37]  A. Guha,et al.  Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.

[38]  R. North,et al.  Rapid secretion of interleukin-1β by microvesicle shedding , 2001 .

[39]  M. Torrisi,et al.  CD8(+) T lymphocytes induce polarized exocytosis of secretory lysosomes by dendritic cells with release of interleukin-1beta and cathepsin D. , 2001, Blood.

[40]  Sanchita Bhatnagar,et al.  Exosome Function: From Tumor Immunology to Pathogen Biology , 2008, Traffic.

[41]  José A López,et al.  Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. , 2005, Blood.

[42]  Y. Okada,et al.  ADAMs in cancer cell proliferation and progression , 2007, Cancer science.

[43]  H. Kwon,et al.  Proteomic analysis of microvesicles derived from human colorectal cancer cells. , 2007, Journal of proteome research.

[44]  Toshihide Kobayashi,et al.  Vesiculation of platelet plasma membranes. Dilauroylglycerophosphocholine-induced shedding of a platelet plasma membrane fraction enriched in acetylcholinesterase activity. , 1984, Biochimica et biophysica acta.

[45]  G. Savettieri,et al.  Neurons produce FGF2 and VEGF and secrete them at least in part by shedding extracellular vesicles , 2007, Journal of cellular and molecular medicine.

[46]  C. Cohen,et al.  Differential mechanisms of microparticle transfer toB cells and monocytes: anti‐inflammatory propertiesof microparticles , 2006, European journal of immunology.

[47]  V. Oberle,et al.  Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils , 2004, Platelets.

[48]  J. Chou,et al.  Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin , 2003, The Journal of experimental medicine.

[49]  F. Di Virgilio,et al.  Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor‐bearing microparticles , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  Simon C Watkins,et al.  Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[51]  J. Meldolesi,et al.  Enlargeosome Traffic: Exocytosis Triggered by Various Signals Is Followed by Endocytosis, Membrane Shedding or Both , 2007, Traffic.

[52]  S. Heptinstall,et al.  Transfer of Tissue Factor from Platelets to Monocytes: Role of Platelet-Derived Microvesicles and CD62P , 2002, Thrombosis and Haemostasis.

[53]  K. Shedden,et al.  Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. , 2003, Cancer research.

[54]  P. Sims,et al.  Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. , 1988, The Journal of biological chemistry.

[55]  K. Preissner,et al.  Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  F. George Microparticles in vascular diseases. , 2008, Thrombosis research.

[57]  R. Andriantsitohaina,et al.  Shed membrane microparticles from circulating and vascular cells in regulating vascular function. , 2005, American journal of physiology. Heart and circulatory physiology.

[58]  B. Rothen‐Rutishauser,et al.  Exovesicles from human activated dendritic cells fuse with resting dendritic cells, allowing them to present alloantigens. , 2006, The American journal of pathology.

[59]  J. Lavail,et al.  The microvesicle as a vehicle for EMMPRIN in tumor–stromal interactions , 2004, Oncogene.

[60]  J. Meldolesi,et al.  Regulated exocytosis: new organelles for non-secretory purposes , 2005, Nature Reviews Molecular Cell Biology.

[61]  A. Angelucci,et al.  Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells. , 2006, International journal of oncology.

[62]  C. Ballantyne,et al.  Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles. , 2008, Blood.

[63]  F. Grinnell,et al.  Stress-relaxation of fibroblasts in collagen matrices triggers ectocytosis of plasma membrane vesicles containing actin, annexins II and VI, and beta 1 integrin receptors. , 1993, Journal of cell science.

[64]  J. Sixma,et al.  Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules , 1999 .

[65]  D. Taylor,et al.  Shedding of plasma membrane fragments. Neoplastic and developmental importance. , 1986, Developmental biology.

[66]  M. Reed,et al.  Tissue factor, angiogenesis and tumour progression , 2008, Breast Cancer Research.

[67]  Johan Skog,et al.  Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.

[68]  Ruixiang Li,et al.  Enrichment and localization of ganglioside G(D3) and caveolin-1 in shed tumor cell membrane vesicles. , 2000, Biochimica et biophysica acta.

[69]  A. Tedgui,et al.  Role of microparticles in atherothrombosis , 2008, Journal of internal medicine.

[70]  J. Schifferli,et al.  Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. , 2004, Blood.

[71]  F. Di Virgilio,et al.  Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. , 2007, Blood.

[72]  S. Meterissian,et al.  Biologically Active Fas Antigen and Its Cognate Ligand Are Expressed on Plasma Membrane-Derived Extracellular Vesicles , 1998 .

[73]  C. Hess,et al.  Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. , 2003, Experimental cell research.

[74]  Luigi Biancone,et al.  Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. , 2007, Blood.

[75]  O. Shimada,et al.  Subsurface cisterna-lined axonal invaginations and double-walled vesicles at the axonal–myelin sheath interface , 2005, Neuroscience Research.

[76]  J. Luzio,et al.  Ectocytosis caused by sublytic autologous complement attack on human neutrophils. The sorting of endogenous plasma-membrane proteins and lipids into shed vesicles. , 1991, The Biochemical journal.

[77]  C. Morris,et al.  Cell Surface Area Regulation and Membrane Tension , 2001, Journal of Membrane Biology.

[78]  J. Freyssinet,et al.  Membrane microparticles: two sides of the coin. , 2005, Physiology.

[79]  M. Berndt,et al.  Platelet physiology and thrombosis. , 2004, Thrombosis research.

[80]  D. Wagner,et al.  The P‐selectin, tissue factor, coagulation triad , 2005, Journal of thrombosis and haemostasis : JTH.